Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The $13.8 million deal is subject to a working capital adjustment
Subscribe to our email newsletter
The AmerisourceBergen has purchased Innomar Strategies, a Canadian specialty pharmaceutical services company, for approximately C$15 million ($13.8 million) in cash, subject to a working capital adjustment.
David Yost, President and CEO of AmerisourceBergen, said: “With Innomar Strategies and our current AmerisourceBergen Specialty Group, Canada, we believe AmerisourceBergen now has the largest and broadest commercialization service offerings to pharmaceutical and biotechnology manufacturers in Canada.”
“This acquisition continues our strategy of acquiring companies within our pharmaceutical distribution and related services focus,” he added.
Innomar provides services within Canada to pharmaceutical and biotechnology companies, including strategic consulting and access solutions, specialty logistics management, patient assistance and nursing services, and clinical research services.